20182018
If you made any changes in Pure these will be visible here soon.

Research Output 2018 2018

2018

Outcomes of ALK positive lung cancer patients treated with crizotinib or second-generation ALK inhibitor: A monoinstitutional experience

De Carlo, E., Del Savio, M. C., Polesel, J., Da Ros, V., Berto, E., Santarossa, S., Chimienti, E., Fratino, L. & Bearz, A., Jan 1 2018, In : Oncotarget. 9, 20, p. 15340-15349 10 p.

Research output: Contribution to journalArticle

Lung Neoplasms
Non-Small Cell Lung Carcinoma
Survival
Retrospective Studies
anaplastic lymphoma kinase

Therapeutic decision based on molecular detection of resistance mechanism in an ALK-rearranged lung cancer patient: A case report

De Carlo, E., Schiappacassi, M., Urbani, M., Doliana, R., Baldassarre, G., Da Ros, V., Santarossa, S., Chimienti, E., Berto, E., Fratino, L. & Bearz, A., Jan 1 2018, In : OncoTargets and Therapy. 11, p. 8945-8950 6 p.

Research output: Contribution to journalArticle

Lung Neoplasms
Mutation
Protein-Tyrosine Kinases
Therapeutics
Biopsy